Participants:

Doina Sirbu Medical Device Innovation LeadUCB PharmaLife Sciences, Pharma & Biotech
Life Sciences, Pharma & Biotech
Doina Sirbu
Medical Device Innovation LeadUCB Pharma
Nader Alaghband Co-Founder & CEOAmpersand Health
Nader Alaghband
Co-Founder & CEOAmpersand Health
Chandana Fitzgerald President, CommunityHLTHOther
Other
Chandana Fitzgerald
President, CommunityHLTH
Astrid Hannich-Walter Dir. Business Model & Healthcare InnovationBoehringer IngelheimOther
Other
Astrid Hannich-Walter
Dir. Business Model & Healthcare InnovationBoehringer Ingelheim
Cristiane Benvenuto Global TA Lead Allergan AestheticsOther
Other
Cristiane Benvenuto
Global TA Lead Allergan Aesthetics
Dario Motti Evidence Lead for Regulated Digital ProductsRoche Hoffman
Dario Motti
Evidence Lead for Regulated Digital ProductsRoche Hoffman
Gaye Bok Parter, AIDIFMGB InnovationOther
Other
Gaye Bok
Parter, AIDIFMGB Innovation
Holger Bartos Head, Global Patient Engagement CenterBoehringer IngelheimOther
Other
Holger Bartos
Head, Global Patient Engagement CenterBoehringer Ingelheim
Kate Wolin, ScD, FACSM, FSBM PartnerPACE Healthcare Capital
Kate Wolin, ScD, FACSM, FSBM
PartnerPACE Healthcare Capital
Louis Payet CEOPeach Health
Louis Payet
CEOPeach Health
Malin Johansson Head of Life ScienceSleep CycleHealth Tech & Solutions
Health Tech & Solutions
Malin Johansson
Head of Life ScienceSleep Cycle
Prem Sreenivasan Clinical Development Health & WellbeingUnilever
Prem Sreenivasan
Clinical Development Health & WellbeingUnilever

About this Meeting

DTx in Dermatology

Join us at 11.00 am EDT

 

There is a growing body of evidence to demonstrate that digital interventions can assist in diagnosis and management of patients living with dermatological conditions. We have seen a flurry of DTx solutions focused on early skin lesions diagnosis and management (e.g for skin cancer), but what are the outcomes so far? Are we really achieving early diagnosis using these tools and do we have clinically validated evidence on this? Besides using digital solutions to diagnose skin cancer and manage skin diseases such as psoriasis or atopic dermatitis, how can DTx products tackle mental health comorbidities (stress, anxiety and depression) associated with dermatology conditions? How can we use digital to have a holistic approach for these patients? Are the current DTx dermatology solutions really aligned with patients, dermatologists, GPs and payers needs?

About Us

HLTH Inc. is a dynamic community delivering unique value to the healthcare industry through a mix of unparalleled global events, inspirational content, and impact-driven initiatives.

USA Event Dates

  • 2026 | HLTH: Nov 15 – 18 | Las Vegas, NV | Register | Sponsor
  • 2027 | ViVE: Mar 14 – 17 | Nashville, TN | Register | Sponsor
  • 2027 | HLTH: Oct 17 – 20 | Las Vegas, NV
  • 2028 | ViVE: Apr 23 – 26 | Fort Lauderdale, FL
  • 2028 | HLTH: Nov 12 – 15 | Las Vegas, NV

Europe Event Dates

  • 2027 | HLTH Europe: Jun 21 – 24 | Amsterdam, NH | Sponsor
  • 2028 | HLTH Europe: Jun 19 – 22 | Amsterdam

Important Notice on Hotel Scams

Any communication that claims to represent HLTH or any third party offering discounted hotel rooms or attendee lists is NOT AFFILIATED with HLTH and should be considered fraudulent. Please book your accommodations only through HLTH’s official channels to ensure authenticity and security.